Possis introduces SafeSeal hemostasis patch to control endovascular bleeding

By Elaine Rigoli

Tampa, Fla., May 11 - Possis Medical, Inc. announced the introduction of the SafeSeal hemostasis hatch, which serves as a topical wound dressing that decreases the time it takes to control bleeding from the puncture made into a blood vessel to perform an endovascular procedure.

Designed to assist manual pressure and complement invasive vessel closure techniques, the SafeSeal patch specifically targets the more than seven million diagnostic and therapeutic procedures performed annually in the United States for coronary and peripheral applications, the company said in a news release.

The SafeSeal patch uses a unique micro-bead material called microporous polysaccharide hemospheres, which works by dehydrating the blood at the wound site causing faster and stronger clotting, the release said.

The SafeSeal patch, with a clear window that aids in positioning the patch and viewing the condition of the wound, enters a U.S. market that the company estimates to be $45 million and growing to $100 million by 2009.

Based in Minneapolis, Possis develops medical devices for the endovascular treatment markets.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.